Practice nurses and the care of patients receiving depot neuroleptic treatment: views on training, confidence and use of structured assessment.
The movement of care into the community for the mentally ill with severe and enduring problems has important implications for primary care services. This paper reports the findings from an interview with practice nurses working in south-west London, United Kingdom, who had participated in a randomised control trial to investigate the effectiveness of training and structured assessment on clinical and social outcomes of patients receiving maintenance medication of depot antipsychotics. The aim of the interview was to explore current practice, attitudes, confidence and priorities for training in relation to these patients. Thirty-nine nurses were interviewed. The majority of practice nurses received scant referral information and worked without protocols. Even though these nurses had received the training, and as a result of the study had increased awareness of the problems of the severely mentally ill, there was a significant relationship between inadequate knowledge of schizophrenia to carry out the task of medication management and lack of confidence. Although the small size of the sample does not permit generalization, important questions are raised for further practice development and research, including the future training needs of practice nurses and partnership relationships with mental health professionals for supervision and support.
Millar
E
E
Section of Community Psychiatry, St George's Hospital Medical School/Kingston University, London.
Garland
C
C
Ross
F
F
Kendrick
T
T
Burns
T
T
D014150:Antipsychotic Agents / Q000008:administration & dosage*; D003692:Delayed-Action Preparations; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D007318:Inservice Training; D008131:London; D008875:Middle Aged; D009730:Nursing Assessment; D011568:Psychiatric Nursing / Q000193:education*; D012559:Schizophrenia / Q000451:nursing*
D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations